261 related articles for article (PubMed ID: 3550093)
21. Regulation of immune complex-mediated complement activation by autoantibodies (F-42) isolated from sera of patients with systemic lupus erythematosus.
Daha MR; Hazevoet HM; Vanes LA
Clin Exp Immunol; 1983 Sep; 53(3):541-6. PubMed ID: 6604604
[TBL] [Abstract][Full Text] [Related]
22. The immunological aspects of sickle cell syndrome with particular reference to circulating immune complexes.
Kazeem AA
East Afr Med J; 1990 Nov; 67(11):761-9. PubMed ID: 2076676
[TBL] [Abstract][Full Text] [Related]
23. [The measurement of IgG class circulating immune complexes in liver diseases using F(ab')2 anti C3 ELISA].
Muratsugu M; Makino M; Kohda H; Sekiya C
Rinsho Byori; 1987 Dec; 35(12):1385-91. PubMed ID: 3502152
[No Abstract] [Full Text] [Related]
24. Studies of circulating immune complexes in ankylosing spondylitis.
Kinsella TD; Lanteigne C; Lewkonia RM; Fritzler MJ
Clin Invest Med; 1982; 5(4):223-30. PubMed ID: 7160109
[TBL] [Abstract][Full Text] [Related]
25. [Immunochemical studies in glomerulonephritis with mesangial immunoglobulin A precipitation].
Kiperova B; Nikolov K; Baleva M; Dzherasi R; Krŭsteva R
Vutr Boles; 1988; 27(4):36-40. PubMed ID: 3213023
[TBL] [Abstract][Full Text] [Related]
26. Stimulation of complement amplification by F(ab')(2)-containing immune complexes and naturally occurring anti-hinge antibodies, possible role in systemic inflammation.
Lutz HU; Fumia S
Autoimmun Rev; 2008 Jun; 7(6):508-13. PubMed ID: 18558371
[TBL] [Abstract][Full Text] [Related]
27. Interaction of C3 with antigen-antibody complexes in the process of solubilization of immune precipitates.
Takata Y; Tamura N; Fujita T
J Immunol; 1984 May; 132(5):2531-7. PubMed ID: 6232320
[TBL] [Abstract][Full Text] [Related]
28. [Functional analysis of immune complex-rich serum fractions in autoimmune diseases by in vitro C3 activation of fresh blood].
Böhm U; Merétey K; Falus A; Bozsóky S
Z Rheumatol; 1981; 40(3):126-30. PubMed ID: 6456623
[TBL] [Abstract][Full Text] [Related]
29. [Circulating immune complexes in hypertrophic cardiomyopathy and ischemic heart disease].
Kardaszewicz B; Rogala E; Tendera M; Kardaszewicz P; Jarzab J
Kardiol Pol; 1991; 34(1):21-4. PubMed ID: 1828843
[TBL] [Abstract][Full Text] [Related]
30. Isolation and characterization of circulating immune complexes in patients with rheumatoid arthritis.
Perego R; Vezzoli S; Manfredi W; Bigi G; Procaccia S
Boll Ist Sieroter Milan; 1983 Nov; 62(5):462-8. PubMed ID: 6608359
[TBL] [Abstract][Full Text] [Related]
31. Anti-C1q column: ligand specific purification of immune complexes from human serum or plasma. Analysis of the interaction between C1q and immune complexes.
Kilgallon W; Amlot PL; Williams BD
Clin Exp Immunol; 1982 Jun; 48(3):705-14. PubMed ID: 6811171
[TBL] [Abstract][Full Text] [Related]
32. Demonstration of apoptosis-associated cleavage products of DNA, complement activation products SC5b-9 and C3d/dg, and immune complexes CIC-C3d, CIC-IgA, and CIC-IgG in the urine of patients with membranous glomerulonephritis.
Kotnik V; Premzl A; Skoberne M; Malovrh T; Kveder R; Kaplan-Pavlovcic S; Kotnik A; Stiblar-Martincic D
Croat Med J; 2003 Dec; 44(6):707-11. PubMed ID: 14652883
[TBL] [Abstract][Full Text] [Related]
33. [Complement components, whole complement activity, and circulating immune complexes in neoplastic diseases].
Takada K; Morishita M; Sugiura T; Suzuki M; Torii Y; Ichimura K; Hashigami H; Toshikawa K; Ina Y; Yamamoto M; Oyama A; Urata A
Gan No Rinsho; 1983 Apr; 29(4):A-19, 293-6. PubMed ID: 6602233
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of C3 deposition on solid-phase bound immune complexes by lactoferrin.
Kievits F; Kijlstra A
Immunology; 1985 Mar; 54(3):449-56. PubMed ID: 3844370
[TBL] [Abstract][Full Text] [Related]
35. Circulating immune complex levels measured by new ELISA kits utilizing monoclonal anti-C1q and anti-C3d antibodies correlate with clinical activities of SLE but not with those of RA.
Yoshinoya S; Mizoguchi Y; Aotsuka S; Yokohari R; Nishioka K; Miyamoto T
J Clin Lab Immunol; 1992; 38(4):161-73. PubMed ID: 11270517
[TBL] [Abstract][Full Text] [Related]
36. Detection of circulating immune complexes in patients with glomerulonephritis.
Szewczyk Z; Falkiewicz K; Kopeć W
Arch Immunol Ther Exp (Warsz); 1978; 26(1-6):577-81. PubMed ID: 373683
[TBL] [Abstract][Full Text] [Related]
37. [Immunological parameters in subjects with essential arterial hypertension. II. Serological observations].
Obbiassi M; Bigi G; Cancellieri V; Palmieri G; Morganti A; Tempesti P; Lettino M
Boll Ist Sieroter Milan; 1982; 61(6):494-8. PubMed ID: 6985421
[TBL] [Abstract][Full Text] [Related]
38. Significance of circulating immune complexes in pulmonary tuberculosis.
Samuel AM; Ashtekar MD; Ganatra RD
Clin Exp Immunol; 1984 Nov; 58(2):317-24. PubMed ID: 6437714
[TBL] [Abstract][Full Text] [Related]
39. [Immune complexes and complement in leprosy (author's transl)].
Geniteau M; Adam C; Verroust P; Pasticier A; Saimot G; Coulaud JP; Languillon J
Nouv Presse Med; 1981 Dec; 10(45):3697-700. PubMed ID: 7322902
[TBL] [Abstract][Full Text] [Related]
40. Circulating IgG complexes in primary biliary cirrhosis. A serial study in forty patients followed for two years.
Gupta RC; Dickson ER; McDuffie FC; Baggenstoss AH
Clin Exp Immunol; 1978 Oct; 34(1):19-27. PubMed ID: 750118
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
